@dt.roth's peptide side effects claims, fact-checked

What did @dt.roth actually say?

The creator's core argument is simple: because peptides like BPC-157 and TB-500 are "amino acid profiles" the body already produces, they essentially cannot cause side effects. The only exception they carve out is IGF-1, which they acknowledge could theoretically accelerate existing cancer. Everything else, in their words, has "no really side effect." That's a strong claim, and it deserves scrutiny.

The framing is appealing. If your body already makes something, flooding it with more sounds harmless. But that logic breaks down quickly when you think about cortisol, insulin, or estrogen. All naturally produced. All capable of causing serious harm in excess or in the wrong context.

Does the science back this up?

Not fully. The honest answer is that the safety profile of most research peptides in humans is largely unknown, because most haven't completed rigorous clinical trials. BPC-157, for instance, has promising animal data, but peer-reviewed human safety data is thin. A 2022 review by Sikiric et al. in Current Pharmaceutical Design highlighted BPC-157's potential in gut and tissue repair, but the authors explicitly noted the absence of large-scale human trials.

TB-500 (thymosin beta-4) has similar gaps. There is early human data from wound-healing studies, but the World Anti-Doping Agency bans it for a reason: its systemic effects on tissue growth are not fully characterized. "No side effects" is not the same as "no reported side effects in limited trials." These are very different statements.

IGF-1's risks are better documented. Laron et al. (1992, New England Journal of Medicine) and subsequent literature have linked supraphysiological IGF-1 to colon cancer risk, acromegaly-like symptoms, and hypoglycemia. The creator gets partial credit here for flagging cancer risk, though they significantly understate the other known risks.

What did they get wrong (or right)?

Wrong: The claim that natural origin equals safety is a logical fallacy. Many endogenous compounds become dangerous when administered exogenously at supraphysiological levels. Water-soluble peptides like BPC-157 and ipamorelin can cause nausea, injection site reactions, flushing, and in the case of GHRPs, elevated cortisol and prolactin. These are documented in the limited trials that do exist.

Right: The creator is correct that IGF-1 stands out as the peptide with the most significant risk profile among those discussed. That's accurate. They're also not wrong that BPC-157 and TB-500 have relatively benign signals in animal and early human data compared to something like synthetic GH.

Wrong: Framing BPC-157's effects as purely side-effect-free is misleading. Reported effects in users include dizziness, nausea, and fatigue. More importantly, because BPC-157 is not FDA-approved for human use, compounded versions have no guaranteed purity or dosing accuracy, which introduces its own risk category entirely.

What should you actually know?

The peptide space operates in a regulatory gray zone. Most of these compounds are sold as "research chemicals" and are not FDA-approved for human use. That doesn't make them automatically dangerous, but it does mean the safety data you'd normally rely on to say "no side effects" simply doesn't exist at scale.

Known and plausible side effects across this class include: injection site reactions, water retention (particularly with MK-677 and some GHRPs), increased hunger, elevated prolactin, transient hypoglycemia with IGF-1, and potential unknown long-term effects from chronic use. For anyone with a history of cancer, autoimmune disease, or metabolic disorders, the risk calculus changes meaningfully.

• BPC-157: Limited human trials. Animal data is promising. Not FDA-approved. Compounded purity is unverified.
• TB-500: WADA-banned. Systemic tissue growth effects not fully characterized in humans.
• IGF-1: Real cancer and hypoglycemia risk. The creator's warning here is warranted but incomplete.
• MK-677: Not technically a peptide. A ghrelin mimetic. Associated with water retention and elevated blood glucose.

The bottom line is that "your body makes it" is not a safety guarantee. Anyone using these compounds should do so under medical supervision and with realistic expectations about what the science currently supports.